FcRH3 Activators
Fc receptor-like 3 (FcRH3) activators are a class of compounds that influence the signaling pathways and cellular processes that FcRH3 is directly involved in, rather than acting as direct ligands or agonists for the receptor. These activators can indirectly lead to the functional enhancement of FcRH3 by modulating the signaling environment of the B cells where FcRH3 is expressed. Compounds such as Forskolin, Ionomycin, and PMA are known to increase the activity of key enzymes and second messengers like PKA, calcium, and PKC, respectively. These molecules play a pivotal role in B cell receptor (BCR) signaling cascades, which FcRH3 is part of. By enhancing these signaling events, the compounds indirectly increase the functional activity of FcRH3.
The indirect activation of FcRH3 through modulation of the signaling environment underscores the complex nature of intracellular signaling networks within B cells. For instance, the enhancement of PKA activity by Forskolin can lead to the phosphorylation of various substrates that contribute to the regulation of gene transcription, cell proliferation, and apoptosis, all of which are critical processes in B cell function and immune response. Similarly, Ionomycin's role in increasing intracellular calcium concentration can trigger a cascade of events that bolster the BCR signaling pathway, affecting the functional role of FcRH3 in processes such as class switching and antibody production. Moreover, PMA's activation of PKC is known to be involved in controlling the activation, differentiation, and survival of B cells. The activation of these enzymes and second messengers does not only enhance the activity of FcRH3 but also the broader immunological functions of B cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels within cells. Elevated cAMP can enhance the PKA signaling pathway, which can phosphorylate proteins involved in B cell receptor (BCR) signaling, potentially enhancing the signaling cascade that FcRH3 is a part of. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Calcium signaling is crucial for B cell activation and function. By elevating intracellular calcium, ionomycin can enhance the calcium-dependent signaling pathways that intersect with BCR signaling, potentially upregulating FcRH3 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). PKC plays a role in multiple signaling pathways, including those in B cells. Activation of PKC can lead to the phosphorylation of proteins that regulate BCR signaling, which could amplify FcRH3 functional activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation by blocking the phosphorylation of IκBα. NF-κB pathway is implicated in B cell development and function. Inhibition of NF-κB may lead to compensatory mechanisms in B cell signaling pathways, potentially enhancing the activity of FcRH3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium levels, similar to ionomycin. By augmenting calcium signaling, A23187 can potentiate signaling pathways in B cells, which might result in enhanced functional activity of FcRH3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K is involved in the B cell receptor signaling cascade. Inhibition of PI3K can lead to changes in the signaling network of B cells, potentially upregulating pathways that increase FcRH3 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. The p38 MAPK pathway is involved in inflammatory responses and B cell differentiation. Inhibition of p38 MAPK can lead to the reorganization of B cell signaling pathways, which might enhance the functional activity of FcRH3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which, like U0126, affects the MAPK/ERK pathway. By modulating this pathway, PD98059 can influence B cell signaling, potentially leading to an increase in FcRH3 activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a PKC inhibitor. While it inhibits PKC, it can lead to compensatory upregulation of other signaling molecules within the B cell, potentially leading to the enhancement of FcRH3 functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. By inhibiting PI3K, it can affect the B cell receptor signaling cascade, potentially resulting in the functional enhancement of FcRH3 through the upregulation of alternative signaling pathways within the B cell network. | ||||||